← Search

Data · dataset · 2022

Tehlirian et al 2022_Suppplementary Material

Listed in Teesside University Research Data Repository

Supplementary material for Tehlirian et al 2022 'Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study'

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 1 source records, 6 field assertions
SourceKeyLast seenRaw
Teesside University Research Data Repositoryoai:data.mendeley.com/w3dp7mtpm2.110 h agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].anzsrc:field:320205mapping · researchdata tees ac ukvocabulary-mapper@1.0.0keywords['Dermatology']
concepts[field].local:field:earth-environmentalmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
descriptionsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/description
license_textsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
publication_datesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
titlesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/title